-
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research
-
iSpecimen completes marketplace integration and launches live platform
-
iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete
-
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research
-
iSpecimen Inc. (ISPC) files for 101M share offering by selling stockholders
-
iSpecimen Inc. (ISPC) files for 1.56M share offering by selling stockholders
-
iSpecimen receives crypto treasury proposals amid $200M digital plan
-
iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions
-
iSpecimen completes first milestone of digital transformation with Salestack
-
iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform
-
iSpecimen Inc. (ISPC) Files for 1.56M Share Offering by Selling Stockholders
-
iSpecimen plans $200M cryptocurrency treasury based on Solana blockchain
-
iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow
-
iSpecimen completes $4 million stock offering at $0.70 per share
-
iSpecimen prices $4 million stock offering at $0.70 per share
-
iSpecimen (ISPC) Secures Suppliers for COVID-style hMPV Outbreak
-
iSpecimen Secures Suppliers for COVID-style hMPV Outbreak
-
iSpecimen (ISPC) to Serve as a Preferred Provider of Cancer Biospecimens
-
iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens
-
iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers
-
iSpecimen Appoints Robert Lim as CEO and Director
-
iSpecimen Named Top Competitor in $4.4 Billion USD Market
-
iSpecimen Inc. (ISPC) Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
-
iSpecimen (ISPC) Secures $1M Loan; Appoints Three New Board Members
-
iSpecimen Inc. (ISPC) Announces 1:20 Reverse Share Split
-
iSpecimen Inc. (ISPC) Tops Q2 EPS by 9c

